Background: Electronic (e)-cigarettes theoretically may be safer than conventional tobacco.
Introduction
Electronic cigarettes (e-cigs) became widely available in 2004-2007 (12) . They are the newest tobacco products on the market, and work by heating and aerosolizing propylene glycol (PG; 1,2-Propanediol), glycerin (Gly; 1,2,3-Propanetriol) and nicotine. The product inhaled is commonly referred to as e-cig vapor (EV). EV has components in common with cigarette smoke, chief among these nicotine, which can directly cause endothelial dysfunction (56). Some EV also contains acrolein, formaldehyde and nitrosamines, which are also commonly found in cigarette smoke. This commonality raises the concern of shared toxicities between cigarettes and e-cigs (17, 19) . The finding that low-tar and smokeless tobacco products may be linked to systemic inflammation and increased cardiovascular disease, further suggests that some of the components of tobacco do not need to undergo combustion in order to be damaging to human health (9, 58).
While the lungs are one of the primary sites of ill effects of cigarette smoke (emphysema and lung cancer), tobacco smoke has significant effects on many other organs, including kidneys, heart, brain and gastrointestinal tract, via induction of endothelial damage and systemic inflammation (2, 56, 60) .
Many human e-cig users pick up the vaping habit as an attempt to help them quit smoking, however some studies and meta analyses to date suggest that e-cig use reinforces the nicotine addiction and decreases the odds of quitting (25, 39). Our own work has demonstrated that chronic inhalation of EV leads to activation of classic nicotine addiction pathways in the central nervous system (1) , which suggests that e-cig users will likely continue using these nicotine delivery devices for years to come. Clinical signals of adverse effects on human health due to long-term use by e-cig users, such as emphysema, cardiovascular disease, and renal dysfunction,
In the current studies, we explored the hypothesis that exposure to the most common components of EV (PG, Gly, and nicotine) alters barrier function of airway epithelium, leading to release of inflammatory proteins into the systemic circulation. Using our in vivo animal model of chronic EV inhalation (32), we assayed serum for evidence of pro-inflammatory effects of EV inhalation, and organs for downstream effects of these pro-inflammatory signals. We specifically evaluated cardiorenal function, as it is known that inhalation of combustible cigarette smoke is detrimental to both cardiac and renal function (30, 63, 74) . One group recently published adverse effects of intraperitoneal injection of e-liquid daily for one month on rat kidney function (28). We sought to confirm these findings using a physiologic exposure to EV, in which e-liquid is placed into a tank, attached to a battery, and the e-liquid is heated and vaporized, producing EV which is inhaled through our nose-only system into the airways. The reason for using this more complex type of exposure is that heating and vaporization of e-liquid alters the chemical composition, and can create toxins such as formaldehyde and acrolein; these toxins may cause adverse effects directly on airway and endothelial cells which the other components of EV do not (34, 72, 77) .
The following in vivo and in vitro studies were designed and undertaken to evaluate whether ecig use leads to inflammation. We present here the effects of daily, chronic inhalation of EV containing nicotine on airway permeability, airway inflammatory response to bacterial infection, the systemic inflammatory milieu, downstream organ function and tissue fibrosis. Informing ecig users, physicians, businesses and policy makers of the potential risks of these new devices may lead to the production of safer devices, new policies to limit access to adults, and safer use patterns by the vaping community -and thus decreased adverse effects on human health overall. transmittance in all wells. When the TEER values reached a plateau, starting on day 21, NHBE cells were transferred to an exposure chamber and EV or Air was introduced for 15 minutes daily for 2-5 days. Each EV breath (50 mL) was produced by pneumatic activation of the e-cig via a 60 mL syringe ( Figure 1B) , with exhalation of the EV onto the apical surface of the NHBE cells, followed by 2 air breaths (50 mL apiece), to mimic the act of breathing. Because EV leaves a greasy residue on exposed surfaces, after exposure, transwells were gently transferred to new wells containing fresh media (380 µL) at the basal interface, and were placed back at 37°C with 5% CO 2 . NHBE barrier function, and specifically permeability due to interruptions in the junctional complex, was evaluated with and without infection with Pseudomonas aeruginosa (PSA; 1x10 6 CFU/well in 50 µL) PAO1 (16), by application of FITC-dextran, molecular weight 3-5,000 (Sigma) to the apical surface for 15 minutes, followed by transfer of 50 µL from the lower transwell chamber to a flat-bottom 96-well plate. The amount of paracellular permeability was measured using a fluorescence plate reader with excitation of 490 nm and emission at 520
nm. NHBE cells were either kept uninfected or were infected with PSA PAO1 (1x10 6 CFU/well in 50 µL) (5). After 2 hours of infection, basolateral supernatant was collected. NHBE cells were harvested either with RLT buffer (Qiagen) or with RIPA buffer and stored at -80°C for RNA and protein studies.
ELISA and Western Blot
The supernatants collected from NHBE cells were measured for IL-8/LIX using the Human IL-8/CXCL8 Quantikine ELISA Kit (R&D systems) following the manufacturer supplied protocol.
For Western Blots, cell lysates were prepared from NHBE cells with ice-cold RIPA buffer containing protease inhibitor (Roche) and phosphatase inhibitor (Sigma) cocktails. An equal amount of protein (50 µg) was loaded in each lane of 8% SDS-PAGE and transferred onto nitrocellulose membrane (Bio-Rad). The membrane was blocked in 5% non-fat milk in TBST (Tris-buffered saline with 0.05% Tween-20), incubated with the tight junction protein antibody for zona occludins (ZO1) (Proteintech; 1:1000) and tubulin (Proteintech; 1:10,000) in 5% milk-TBST for incubation overnight at 4°C. ZO1 was detected at a molecular weight of 195 kD, while tubulin was detected at a molecular weight of 55 kD. After imaging, blots were opened in ImageJ, converted to 8-bit files, background removed via adjustment of the threshold to Huang, and the integrated density of each band was measured.
Animals
Six to eight week-old female C57BL/6 and CD-1 (ICR) mice were purchased from Harlan (Envigo). Inbred C57BL/6 mice are known to be susceptible to emphysema and oxidative stress (29), while outbred CD-1 mice are resistant (14). Mice were acclimated to the individual, soft mesh restraints (SciReq) for 30 min daily for 2 days. Mice were then exposed to EV daily, for 5 days per week, for 3-6 months, using the nose-only InExpose system (SciReq) as we previously described (32), using a flow rate of 2 L/minute and exposure time of 4 seconds of EV every 20 seconds for 60 minutes daily (7). Because C57BL/6 mice are more susceptible to pathologic effects of smoke inhalation (emphysema), and more susceptible to disease in general, the exposure for 60 minutes. C57BL/6 mice were exposed to EV or Air daily for 3 months. CD-1 mice were exposed to EV or Air daily for 6 months. All mice were placed in pre-warmed cages for 30 minutes to recover after restraint. The last exposure was done the day of harvest, with mice being placed on a warming pad for heart rate and blood pressure measurements (15-30min post-exposure), followed by application of anesthesia, terminal intracardiac bleed and organ harvest. Animal experiments were conducted in accordance with the National Institutes of 
Circulating pro-inflammatory cytokines
Blood was placed at 4°C for 15 min, spun at 3,000 rpm for 15 min at 4°C, and plasma stored at -80°C for measurement of total protein (BCA Total Protein Assay Kit; Pierce) and inflammatory cytokines via Mouse XL Cytokine Array (Proteome Profiler by R&D), according to the manufacturer's instructions. In brief, for CD-1 mice, plasma samples were individually checked for protein concentration prior to pooling for proteome array, with equal volumes of plasma from individual mice combined into one sample (n = 6 for both groups). Individual plasma samples from C57BL/6 mice were run (n = 3 for both groups). Proteome films were blinded, scanned, uploaded to imageJ, background removed via threshold adjustment, and pixel density for each pair of cytokine dots quantified. Data is presented as a ratio of EV to Air.
To determine glomerular filtration rate (GFR), the week prior to harvest, mice were exposed to EV or Air for 60min, and allowed to recover for 60 minutes. Mice were placed under inhaled isoflurane anesthesia and FITC-sinistrin (2 µl/g body weight) was injected retro-orbitally with a 30G needle. Subsequently, the anesthetized mouse fully regained consciousness. Tail vein puncture was utilized to collect blood in 10 µL Na-Heparin Minicaps at the following times after injection: 3, 5, 7, 10, 15, 35, 56, and 75 minutes. Samples were analyzed for FITC-Sinistrin concentration using a NanoDrop 3300.
Cardiac Function
For the week prior to harvest, EV and Air mice underwent heart rate (HR) and blood pressure (BP) monitoring for 30 minutes after EV or Air exposure (n = 6 for all groups). HR and BP were obtained using a CODA Monitor, non-invasive BP system (Kent Scientific) as described previously (23, 42, 43). We concomitantly checked HR via pulse oximeter by PhysioSuite (Kent Scientific).
Renal, cardiac and liver fibrosis evaluation
Mice were anesthetized with ketamine (100 mg/kg) and xylazine (10 mg/mL) and euthanized, by a terminal intracardiac bleed. The right kidney, one lobe of liver and the base of the heart were then immediately dissected and placed in Z-fix at 4°C. After 48 hours all organs were moved to 75% ethanol and submitted to the UCSD histology core for paraffin embedding. Collagen was detected in 5 µm sections first by Masson's trichrome stain. All histology slides underwent quantification of fibrosis by calculating the mean percent fibrotic area in > 30 randomly acquired 20x images using computer aided morphometry performed using a macro in ImageJ as previously described (23, 31, 42, 43). Collagen deposition was also detected by 5 µm sections on Picrosirius red staining. All histology slides were blinded and underwent quantification under bright field microscopy by calculating a relative area of brightness at a set threshold (157,255), in relation to the area of 6 randomly acquired 10x images, computer aided morphometry performed using an ImageJ macro (https://imagej.nih.gov/ij/docs/examples/stainedsections/index.html). All slides underwent these computer analyses in an identical fashion.
Fibrotic area is presented relative to that of air controls.
Quantification of fibrosis markers in renal and cardiac parenchyma
After daily exposure to EV for 5 days per week, for four weeks (1 month), the left kidney and the apex of the heart from both CD-1 and C57BL/6 Air and EV mice were snap frozen and stored at 
Statistical analyses:
Data are presented as means ± Standard Error of the Mean (SEM). Data obtained were analyzed by t-test or by two-way ANOVA, where appropriate. Analyses were conducted using Graph Pad Prism 6 software.
Results

E-cigarette vapor inhalation increased the levels of circulating inflammatory cytokines
We hypothesized that repetitive inhalation of EV leads to stress in or damage to pulmonary epithelial cells, which leads to the release of factors into systemic circulation. In mice inhaling one hour of EV daily, for 5 days per week, we found higher levels of several inflammatory cytokines in the circulation (significance was defined as a 20% change compared with Air control mice), and lower levels as well (Figures 2A-B ). Proteins that changed in both strains of mice (*) are of particular interest since these changes were induced by chronic EV inhalation across genetically different backgrounds (Table 1) . Proteins from the same family (such as metalloproteases MMP-9 and MMP-2) that had changes in quantity across the two strains are also demarcated (✢). Overall, the finding of changes in expression, production or secretion of multiple inflammatory protein levels, both increases and decreases, suggests that chronic EV inhalation causes systemic immunomodulation.
To begin to understand where the immunomodulatory signals originate we evaluated the inflammatory state of the lungs. Lungs from CD-1 mice were examined and had normal histopathology ( Figure 3A ). Within the bronchoalveolar lavage (BAL), dipeptidyl peptidase-4
(DPPIV / CD26) was elevated 1.7-fold in EV mice versus controls ( Figure 3B ). DPPIV is an enzyme expressed on the surface of cells. It is an intrinsic membrane glycoprotein and has general immune regulation and signal transduction functions. DPPIV has been shown to modulate macrophage M1/M2 polarization (86) and modulate T-cell recruitment to the lungs (49, 71), while inhibition of DPPIV decreases T-cell mediated inflammation (73) . DPPIV is thought to play a pathologic role in the development of liver, cardiac, and kidney fibrosis (3, 37,
40, 69).
Nicotine itself has effects on endothelial cell function. The nicotine metabolite cotinine was measured in all mice immediately after the final 60 minute EV or air exposure. C57BL/6 mice exposed to EV had an average plasma cotinine level of 268.8 ng/mL versus 25.6 ng/mL in Air controls, while CD1 female mice exposed to EV had an average of 287.9 ng/mL plasma cotinine, fibrosis) than did air controls (1.88-fold increase, p < 0.05; Figure 5C ). Blinded evaluation of Picrosirius red stained renal parenchyma ( Figure 5B ) confirmed higher deposition of collagen in EV kidneys compared to air controls (1.62-fold increase, p = 0.034; Figure 5D ). These data suggest that regular EV inhalation may have pro-fibrotic effects on kidney parenchyma, which could lead to decreased renal function after a relatively short duration of exposure.
Long term e-cigarette exposure in outbred CD-1 mice also induced renal fibrosis
When genetically diverse, and thus hardier, CD-1 mice were exposed to 1 hour daily of EV for 6 months, they also developed renal fibrosis ( Figure 6A ). By trichrome staining, EV kidney parenchyma had a 3.2-fold increase in fibrosis compared with experimental controls (p = 0.022; Figure 6B ). By Picrosirius red staining, EV kidney parenchyma had 2.14-fold higher collagen deposition compared to air controls (p < 0.01; Figure 6C ). These data suggest that chronic inhalation of EV leads to activation of pro-fibrotic pathways systemically, impacting nonpulmonary organs. Changes in pro-fibrotic gene expression were also observed at earlier times ( Figure 6D -K). These data add confidence to our findings that fibrosis is stimulated by EV exposure since outbred CD-1 mice are genetically diverse, with higher likelihood of results being translatable to human subjects.
Recent work in our lab has revealed that decreased tissue expression of miR-29b-3p is a mechanism of cardiorenal toxicity and organ fibrosis in chronic kidney disease and in response to combustible cigarette exposure (21, 22, 48). We found molecular evidence of early profibrotic changes in renal tissues of EV exposed mice at 1 month -lower expression of the anti-fibrotic miRNA miR-29b-3p ( Figure 6D ) and higher expression of collagen-1 within CD-1 renal parenchyma ( Figure 6E ). The expression of additional pro-fibrotic factors, Col3a1, Col4a1, Itgb1, and Fbn1, were all significantly increased in renal tissues from e-cigarette exposed animals (p < 0.05; Figs. 6F, 6G, 6I, and 6J). Extracellular matrix remodeling factor Mmp2 trended up, but not significantly ( Figure 6H ). The fibrosis component Eln trended down ( Figure   6K ). When we completed similar renal studies with our collaborators studying renal fibrosis in a cigarette smoke (CS) inhalation model, we found a similar fibrosis pattern (21). These data suggest that a shared component of EV and CS, such as nicotine, may be the etiologic agent in distant organ injury and fibrosis.
Chronic e-cigarette vapor inhalation induced cardiac fibrosis and altered cardiovascular function
Examination of cardiac tissue revealed a 2.75-fold greater level of fibrosis in hearts from CD-1 mice exposed to EV for 6 months compared with controls (p < 0.001; Figures 7A-B) . When we examined hearts after only 4 weeks of daily EV exposure, we found increased expression of collagen-3 (p < 0.05; Figure 7C ), although levels of collagen-1 were not elevated ( Figure 7D ).
These data extend our findings from kidney to heart and thus suggest global pro-fibrotic signaling induced by chronic EV inhalation.
We evaluated cardiovascular function in the C57BL/6 mice exposed to EV for 3 months, and found decreased heart rates (HR), as compared with air controls (p < 0.01; Figure 7E ). EV mice also tended to have more HR variability (oscillations between consecutive instantaneous HR; Discussion E-cigarettes are considered by many to be safer than conventional cigarettes. While this is most likely the case in terms of carcinogenesis (81) , conclusions as to their general safety have yet to be made. We present here, for the first time, evidence that chronic e-cigarette use negatively impacts multiple organs in mammals of different genetic backgrounds. Daily inhalation of EV made from PG, Gly and 24 mg/mL nicotine for 3 or 6 months led to fibrosis in heart, kidney, and liver tissues, with concomitant changes in cardiac and renal function. In vitro data suggest that toxic components of EV may be disrupting airway epithelium, triggering cells to secrete profibrotic proteins into circulating blood, leading to damage to multiple organs. Although all three organs affected in our studies had a similar pattern of fibrosis, gene expression changes were not identical. Kidney parenchyma had elevations in Col1a1 and Col3a1 at 1 month, while cardiac tissue only had elevation of Col3a1. The regulation of these two collagens in the myocardium is known to be via complex and diverse mechanisms (8, 57). Different organ systems are known to respond to stress and inflammation in different ways, and over different time frames (24).
Myofibroblasts arise from stromal cells within each organ and are the primary sources of extracellular matrix protein production. Because myofibroblasts have organ-environment based differences in gene expression, which leads to functional heterogeneity, there are differences in the types of collagen deposited, and the timing thereof, for myofibroblasts from cardiac, renal and hepatic tissues. Although extensive research has been done on fibrosis, there is still much unknown about the multitude of cellular and molecular pathways in fibrosis induction, progression and termination.
Increased levels of circulating inflammatory proteins due to chronic EV exposure
To determine potential pathways through which multi-organ fibrosis is incurred, inflammatory protein profiles were examined using plasma from two mouse strains (C57BL/6 -individual samples; CD-1 -pooled samples). We report here only proteins that were different by 20% or more in EV mice relative to Air controls, as changes of that magnitude have a greater likelihood of potential biologic effects. We focused on changes in circulating inflammatory proteins that occurred in both C57BL/6 and CD-1 strains, as activation of inflammatory pathways in disparate genetic backgrounds are more likely to be associated with the downstream organ damage and fibrosis that was found in our models.
Leukemia Inhibitory Factor (LIF) is a member of the IL-6 cytokine family and is commonly systemically elevated in the setting of inflammation (62) . LIF was elevated in the circulation of EV mice, as compared with Air, with a 30.6-fold increase in C57BL/6 mice and a 6.3-fold increase in CD-1 mice (Table 1) . LIF is involved with regulation of cell differentiation, proliferation, and survival, via activation of both the JAK/STAT3 and MAPK pathways, which increase the ability of tumor cells to invade. More importantly, LIF is produced by pulmonary cells, including epithelial, smooth muscle and innate immune cells, in response to stressful stimuli, including inhalation of air pollution and endotoxin (47), and is thought to confer protection (78) , even in the setting of ARDS. Elevations of circulating LIF in our models suggests that inhalation of EV induces stress on pulmonary cells, leading to production and release of LIF as a protective response. Increased LIF also suggests increased autophagy, which may be an adaptive response to stress or lead to cell death, and LIF is known to increase EGF expression, which experienced a 24.6-fold increase in the plasma of C57BL/6 EV mice, and a 2.1-fold increase in the plasma of CD-1 EV mice (Table 1) . Elevated LIF and EGF suggest that EV mice may have systemic increases in cell-proliferation signals.
Angiopoietin 1 (Ang-1) was increased in EV plasma from C57BL/6 and CD-1 mice, compared with experimental controls (27-fold and 1.38-fold higher in EV versus Air, respectively). In human smokers, Ang-1 has been found to be elevated in the blood, before mild, moderate or severe COPD develops (45). This may be due to ongoing vascular remodeling secondary to damage by cigarette smoke inhalation. In a C57BL/6 mouse model of renal injury, Ang-1 was
shown to be elevated in the setting of increased fibrosis (84) . It has been demonstrated that But these lower levels of MMP-3 may also be evidence of increased risk of carcinogenesis.
Chitinase 3-like 1 (YKL-40) was decreased 38.9-fold in C57BL/6, and 1.22-fold decreased in CD-1 mice. Chitinase 3-like 1 is also elevated in neutrophilic inflammation and is thought to be secreted more by pro-inflammatory macrophage phenotypes, and less so by anti-inflammatory macrophages (50). One hypothesis of why YKL-40 is diminished in the setting of chronic EV inhalation is that the nicotine within the EV activated anti-inflammatory pathways (11), leading to a shift to anti-inflammatory monocytes in the circulation.
WISP-1 is associated with pathologic processes including inflammation, tissue repair, and cancer (26). WISP-1 was decreased 2.15-fold in C57BL/6, and 1.49-fold decreased in CD-1 mice.
However, the significance of these changes is unclear, as elevated circulating WISP-1 has been associated with renal fibrosis (85) and in cancer studies, WISP-1 levels tend to be elevated as well (53, 80).
One of the limitations of our studies was the use of pooled plasma samples from CD-1 mice for the proteome array studies, as pooling of samples can mask biological variance. We focused on changes only found in both strains, to increase the likelihood of detecting changes associated with the organ fibrosis seen in both strains. Further studies will be needed to assess the biological importance of the differences found, and determine the mechanistic underpinnings.
Relevance of our data to human e-cigarette vapers
These studies were done with commercially purchased e-cigarette batteries, tanks and e-liquids, with puff topography for in vivo studies based off of current use patterns to best mimic human use. We included the most common ingredients found in e-liquids: PG, Gly and nicotine. Thus, humans using the same or similar devices (Vape pens) and e-liquids could be at risk for the effects seen in our models. However, because of the wide variety of e-cigarette devices and eliquids on the market, and the variability across batches, our findings from one brand may not be Our findings of multi-organ dysfunction and fibrosis induced by regular inhalation of EV produced by vape pens illustrate the need to expand clinical, epidemiological, and basic science research studies to include possible effects on organ systems outside of the pulmonary system.
Our findings of significant pathophysiologic affects caused by inhalation of non-flavored EV
give credence to the belief that there are toxic effects of EV components, beyond those of flavorings alone. The data presented here highlight the need to devote more resources to study these increasingly popular nicotine delivery devices.
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Figure Legends Quantitative analysis of EV relative to control determined that EV livers exposed to EV daily for 6 months had 1. Table 1 . Circulating inflammatory proteins that changed in both C57BL/6 and CD-1 mice chronically exposed to EV. Proteins which were elevated in the plasma of EV mice are in blue, and proteins which decreased in the plasma of EV mice are in orange. 
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